[144] Ares Management Corporation SEC Filing

Rhea-AI Filing Summary

Ares Management Corporation (ARES) filer submitted a Form 144 to notify a proposed sale of 300,000 shares of common stock through Morgan Stanley Smith Barney LLC. The filing states the aggregate market value of the shares at approximately $54,177,000 and reports 215,934,693 shares outstanding. The approximate date of sale is 08/20/2025. The securities were acquired as Founders Shares on 05/01/2014 from the issuer and the filer reports no sales in the prior three months. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information.

Positive

• Required disclosure elements are provided: broker, share count, aggregate market value, acquisition date, and purchase origin.
• Seller attests they are not aware of undisclosed material adverse information about the issuer.

Negative

• Large block size: 300,000 shares with an aggregate market value of $54,177,000 could represent meaningful supply to the market.
• No indication in the filing of reliance on a Rule 10b5-1 trading plan or plan adoption date, which would clarify timing and defenses.

Insights

Financial Analyst

TL;DR: A large block of 300,000 ARES shares (~$54.2M) is being positioned for sale; monitor potential share supply impact on near-term trading.

The filing documents a proposed sale of 300,000 common shares via Morgan Stanley Smith Barney with an aggregate market value of $54,177,000 and an approximate sale date of 08/20/2025. The shares were acquired as founders shares on 05/01/2014 from the issuer. The filing does not disclose the seller's identity beyond the required representation or provide any plan details such as staged disposition or 10b5-1 plan adoption date. Without additional context on timing or whether the sale will be executed in a single block or over time, the filing confirms a material amount of securities will be available to the market but does not by itself quantify market-impact or intent.

Compliance Officer

TL;DR: The Form 144 provides required disclosure elements and the seller attests to no undisclosed material adverse information.

The notice includes required fields: broker name and address, class of securities, number of shares, aggregate market value, outstanding shares, acquisition date and nature (founders shares), and representation regarding material non-public information. The filing indicates no securities sold by the filer in the past three months. The submission presents the necessary compliance attestations but does not state reliance on a Rule 10b5-1 trading plan or provide a plan adoption date, which would be relevant for assessing affirmative defenses to insider trading allegations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	300000	54177000.00	215934693	08/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2014	Founders Shares	Issuer			300000	05/01/2014	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does ARES Form 144 disclose about the proposed sale?

The Form 144 notifies a proposed sale of 300,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $54,177,000 and an approximate sale date of 08/20/2025.

When were the ARES shares being sold originally acquired?

The shares were acquired as Founders Shares on 05/01/2014 from the issuer, and the filing shows 300,000 shares to be sold.

Does the Form 144 indicate any shares were sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Who is the broker listed in the ARES Form 144?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza 8th Floor, New York NY 10004.

Does the filing state reliance on a Rule 10b5-1 plan?

The filing does not provide a date of plan adoption or state explicit reliance on a Rule 10b5-1 trading plan.